{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:40:24Z","timestamp":1791157224189,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,7,22]],"date-time":"2008-07-22T00:00:00Z","timestamp":1216684800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1007\/s00277-008-0544-2","type":"journal-article","created":{"date-parts":[[2008,7,21]],"date-time":"2008-07-21T05:01:12Z","timestamp":1216616472000},"page":"111-119","source":"Crossref","is-referenced-by-count":28,"title":["Clinical features and prognostic factors of patients with \u201cperipheral T cell lymphoma, unspecified\u201d"],"prefix":"10.1007","volume":"88","author":[{"given":"Yuna","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Eun","family":"Uhm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Jae","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeongsu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk Joong","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Ho","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kihyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul Won","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Chan","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keunchil","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hyeh","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Seog","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,7,22]]},"reference":[{"key":"544_CR1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/1042819021000030054","volume":"44","author":"ER Arrowsmith","year":"2003","unstructured":"Arrowsmith ER, Macon WR, Kinney MC, Stein RS, Goodman SA, Morgan DS, Flexner JM, Cousar JB, Jagasia MH, McCurley TL, Greer JP (2003) Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification. Leuk Lymphoma 44:241\u2013249","journal-title":"Leuk Lymphoma"},{"key":"544_CR2","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/sj.onc.1209178","volume":"25","author":"B Ballester","year":"2006","unstructured":"Ballester B, Ramuz O, Gisselbrecht C, Doucet G, Loi L, Loriod B, Bertucci F, Bouabdallah R, Devilard E, Carbuccia N, Mozziconacci MJ, Birnbaum D, Brousset P, Berger F, Salles G, Briere J, Houlgatte R, Gaulard P, Xerri L (2006) Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas. Oncogene 25:1560\u20131570","journal-title":"Oncogene"},{"key":"544_CR3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/10428190601078118","volume":"48","author":"L Brepoels","year":"2007","unstructured":"Brepoels L, Stroobants S, Verhoef G (2007) PET and PET\/CT for response evaluation in lymphoma: current practice and developments. Leuk Lymphoma 48:270\u2013282","journal-title":"Leuk Lymphoma"},{"key":"544_CR4","first-page":"607","volume":"132","author":"SB Cogliatti","year":"2002","unstructured":"Cogliatti SB, Schmid U (2002) Who is WHO and what was REAL? Swiss Med Wkly 132:607\u2013617","journal-title":"Swiss Med Wkly"},{"key":"544_CR5","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2006-04-017632","volume":"108","author":"J Dupuis","year":"2006","unstructured":"Dupuis J, Emile JF, Mounier N, Gisselbrecht C, Martin-Garcia N, Petrella T, Bouabdallah R, Berger F, Delmer A, Coiffier B, Reyes F, Gaulard P (2006) Prognostic significance of Epstein\u2013Barr virus in nodal peripheral T-cell lymphoma, unspecified: a Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA) study. Blood 108:4163\u20134169","journal-title":"Blood"},{"key":"544_CR6","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/cncr.20999","volume":"103","author":"MP Escalon","year":"2005","unstructured":"Escalon MP, Liu NS, Yang Y, Hess M, Walker PL, Smith TL, Dang NH (2005) Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience.. Cancer 103:2091\u20132098","journal-title":"Cancer"},{"key":"544_CR7","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","volume":"103","author":"A Gallamini","year":"2004","unstructured":"Gallamini A, Stelitano C, Calvi R, Bellei M, Mattei D, Vitolo U, Morabito F, Martelli M, Brusamolino E, Iannitto E, Zaja F, Cortelazzo S, Rigacci L, Devizzi L, Todeschini G, Santini G, Brugiatelli M, Federico M (2004) Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 103:2474\u20132479","journal-title":"Blood"},{"key":"544_CR8","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2007-02-074641","volume":"110","author":"A Gallamini","year":"2007","unstructured":"Gallamini A, Zaja F, Patti C, Billio A, Specchia MR, Tucci A, Levis A, Manna A, Secondo V, Rigacci L, Pinto A, Iannitto E, Zoli V, Torchio P, Pileri S, Tarella C (2007) Alemtuzumab (campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial. Blood 110:2316\u20132323","journal-title":"Blood"},{"key":"544_CR9","first-page":"76","volume":"92","author":"C Gisselbrecht","year":"1998","unstructured":"Gisselbrecht C, Gaulard P, Lepage E, Coiffier B, Briere J, Haioun C, Cazals-Hatem D, Bosly A, Xerri L, Tilly H, Berger F, Bouhabdallah R, Diebold J (1998) Prognostic significance of T-cell phenotype in aggressive non-Hodgkin\u2019s lymphomas. Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte (GELA). Blood 92:76\u201382","journal-title":"Blood"},{"key":"544_CR10","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1023\/A:1008375931236","volume":"10","author":"NL Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD (1999) The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol 10:1419\u20131432","journal-title":"Ann Oncol"},{"key":"544_CR11","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3816\/CLM.2007.n.044","volume":"7","author":"IG Hwang","year":"2007","unstructured":"Hwang IG, Yoo KH, Lee SH, Park YH, Lim TK, Lee SC, Park S, Park B-B, Ko YH, Kim K, Koo HH, Kim WS (2007) Clinicopathologic features and treatment outcomes in malignant lymphoma of pediatric and young adult patients in Korea: comparison with Korean all-ages group and Western younger age group. Clin Lymphoma Myeloma 7:580\u2013586","journal-title":"Clin Lymphoma Myeloma"},{"key":"544_CR12","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1200\/JCO.2005.01.891","volume":"23","author":"ME Juweid","year":"2005","unstructured":"Juweid ME, Wiseman GA, Vose JM, Ritchie JM, Menda Y, Wooldridge JE, Mottaghy FM, Rohren EM, Blumstein NM, Stolpen A, Link BK, Reske SN, Graham MM, Cheson BD (2005) Response assessment of aggressive non-Hodgkin\u2019s lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography. J Clin Oncol 23:4652\u20134661","journal-title":"J Clin Oncol"},{"key":"544_CR13","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/annonc\/mdm265","volume":"18","author":"S Kako","year":"2007","unstructured":"Kako S, Izutsu K, Ota Y, Minatani Y, Sugaya M, Momose T, Ohtomo K, Kanda Y, Chiba S, Motokura T, Kurokawa M (2007) FDG-PET in T-cell and NK-cell neoplasms. Ann Oncol 18:1685\u20131690","journal-title":"Ann Oncol"},{"key":"544_CR14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0959-8049(01)00344-6","volume":"38","author":"K Kim","year":"2002","unstructured":"Kim K, Kim WS, Jung CW, Im YH, Kang WK, Lee MH, Park CH, Ko YH, Ree HJ, Park K (2002) Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European\u2013American lymphoma (REAL) classification. Eur J Cancer 38:75\u201381","journal-title":"Eur J Cancer"},{"key":"544_CR15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00280-007-0469-9","volume":"60","author":"JG Kim","year":"2007","unstructured":"Kim JG, Sohn SK, Chae YS, Cho YY, Yang DH, Lee JJ, Kim HJ, Shin HJ, Chung JS, Cho GJ, Lee WS, Joo YD, Sohn CH, Oh SJ (2007) Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II study. Cancer Chemother Pharmacol 60:129\u2013134","journal-title":"Cancer Chemother Pharmacol"},{"key":"544_CR16","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/(SICI)1097-0142(19980815)83:4<806::AID-CNCR26>3.0.CO;2-V","volume":"83","author":"YH Ko","year":"1998","unstructured":"Ko YH, Kim CW, Park CS, Jang HK, Lee SS, Kim SH, Ree HJ, Lee JD, Kim SW, Huh JR (1998) REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular study group of the Korean society of pathologists. Revised European\u2013American lymphoma. Cancer 83:806\u2013812","journal-title":"Cancer"},{"key":"544_CR17","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.leukres.2004.04.016","volume":"28","author":"H Kojima","year":"2004","unstructured":"Kojima H, Hasegawa Y, Suzukawa K, Mukai HY, Kaneko S, Kobayashi T, Kamoshita M, Shinagawa A, Komeno T, Komatsu T, Mitsuhashi S, Kawachi Y, Yamashita Y, Mori N, Nagasawa T (2004) Clinicopathological features and prognostic factors of Japanese patients with \u201cperipheral T-cell lymphoma, unspecified\u201d diagnosed according to the WHO classification. Leuk Res 28:1287\u20131292","journal-title":"Leuk Res"},{"key":"544_CR18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","volume":"24","author":"J Lee","year":"2006","unstructured":"Lee J, Suh C, Park YH, Ko YH, Bang SM, Lee JH, Lee DH, Huh J, Oh SY, Kwon HC, Kim HJ, Lee SI, Kim JH, Park J, Oh SJ, Kim K, Jung C, Park K, Kim WS (2006) Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 24:612\u2013618","journal-title":"J Clin Oncol"},{"key":"544_CR19","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1023\/A:1008418727472","volume":"9","author":"A Lopez-Guillermo","year":"1998","unstructured":"Lopez-Guillermo A, Cid J, Salar A, Lopez A, Montalban C, Castrillo JM, Gonzalez M, Ribera JM, Brunet S, Garcia-Conde J, Fernandez de Sevilla A, Bosch F, Montserrat E (1998) Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. classification. Ann Oncol 9:849\u2013855","journal-title":"Ann Oncol"},{"key":"544_CR20","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/cncr.20531","volume":"101","author":"F Morabito","year":"2004","unstructured":"Morabito F, Gallamini A, Stelitano C, Callea V, Guglielmi C, Neri S, Lazzaro A, Orsucci L, Ilariucci F, Sacchi S, Vitolo U, Federico M (2004) Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B-cell lymphomas: experience of the Intergruppo Italiano Linformi. Cancer 101:1601\u20131608","journal-title":"Cancer"},{"key":"544_CR21","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1080\/10428190601123989","volume":"48","author":"BB Park","year":"2007","unstructured":"Park BB, Ryoo BY, Lee JH, Kwon HC, Yang SH, Kang HJ, Kim HJ, Oh SY, Ko YH, Huh JR, Lee SS, Nam EM, Park KW, Kim JH, Kang JH, Bang SM, Park S, Kim K, Park K, Suh C, Kim WS (2007) Clinical features and treatment outcomes of angioimmunoblastic T-cell lymphoma. Leuk Lymphoma 48:716\u2013722","journal-title":"Leuk Lymphoma"},{"key":"544_CR22","first-page":"1372","volume":"88","author":"J Rodriguez","year":"2003","unstructured":"Rodriguez J, Caballero MD, Gutierrez A, Gandarillas M, Sierra J, Lopez-Guillermo A, Sureda A, Zuazu J, Marin J, Arranz R, Carreras E, Leon A, De Sevilla AF, San Miguel JF, Conde E (2003) High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experience. Haematologica 88:1372\u20131377","journal-title":"Haematologica"},{"key":"544_CR23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/asheducation-2005.1.267","volume":"2005","author":"KJ Savage","year":"2005","unstructured":"Savage KJ (2005) Aggressive peripheral T-cell lymphomas (specified and unspecified types). Hematology Am Soc Hematol Educ Program 2005:267\u2013277","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"544_CR24","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/annonc\/mdh392","volume":"15","author":"KJ Savage","year":"2004","unstructured":"Savage KJ, Chhanabhai M, Gascoyne RD, Connors JM (2004) Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol 15:1467\u20131475","journal-title":"Ann Oncol"},{"key":"544_CR25","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1046\/j.1365-2141.2003.04203.x","volume":"120","author":"KW Song","year":"2003","unstructured":"Song KW, Mollee P, Keating A, Crump M (2003) Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype. Br J Haematol 120:978\u2013985","journal-title":"Br J Haematol"},{"key":"544_CR26","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2141.2005.05478.x","volume":"129","author":"R Sonnen","year":"2005","unstructured":"Sonnen R, Schmidt WP, Muller-Hermelink HK, Schmitz N (2005) The International Prognostic Index determines the outcome of patients with nodal mature T-cell lymphomas. Br J Haematol 129:366\u2013372","journal-title":"Br J Haematol"},{"key":"544_CR27","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1182\/blood.V96.6.2172","volume":"96","author":"R Suzuki","year":"2000","unstructured":"Suzuki R, Kagami Y, Takeuchi K, Kami M, Okamoto M, Ichinohasama R, Mori N, Kojima M, Yoshino T, Yamabe H, Shiota M, Mori S, Ogura M, Hamajima N, Seto M, Suchi T, Morishima Y, Nakamura S (2000) Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T\/null cell phenotype. Blood 96:2993\u20133000","journal-title":"Blood"},{"key":"544_CR28","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/blood-2002-05-1352","volume":"103","author":"T Tsuchiya","year":"2004","unstructured":"Tsuchiya T, Ohshima K, Karube K, Yamaguchi T, Suefuji H, Hamasaki M, Kawasaki C, Suzumiya J, Tomonaga M, Kikuchi M (2004) Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL. Blood 103:236\u2013241","journal-title":"Blood"},{"key":"544_CR29","first-page":"811","volume":"106","author":"JM Vose","year":"2005","unstructured":"Vose JM, The International PP (2005) International Peripheral T-Cell Lymphoma (PTCL) clinical and pathologic review project: poor outcome by prognostic indices and lack of efficacy with anthracyclines. ASH Annu Meet Abstr 106:811","journal-title":"ASH Annu Meet Abstr"},{"key":"544_CR30","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","volume":"24","author":"P Went","year":"2006","unstructured":"Went P, Agostinelli C, Gallamini A, Piccaluga PP, Ascani S, Sabattini E, Bacci F, Falini B, Motta T, Paulli M, Artusi T, Piccioli M, Zinzani PL, Pileri SA (2006) Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol 24:2472\u20132479","journal-title":"J Clin Oncol"},{"key":"544_CR31","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/annonc\/mdh427","volume":"15","author":"S Wohrer","year":"2004","unstructured":"Wohrer S, Chott A, Drach J, Puspok A, Hejna M, Hoffmann M, Raderer M (2004) Chemotherapy with cyclophosphamide, doxorubicin, etoposide, vincristine and prednisone (CHOEP) is not effective in patients with enteropathy-type intestinal T-cell lymphoma. Ann Oncol 15:1680\u20131683","journal-title":"Ann Oncol"},{"key":"544_CR32","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.2007.11.4207","volume":"25","author":"PL Zinzani","year":"2007","unstructured":"Zinzani PL, Musuraca G, Tani M, Stefoni V, Marchi E, Fina M, Pellegrini C, Alinari L, Derenzini E, de Vivo A, Sabattini E, Pileri S, Baccarani M (2007) Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma. J Clin Oncol 25:4293\u20134297","journal-title":"J Clin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-008-0544-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-008-0544-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-008-0544-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T04:21:35Z","timestamp":1588825295000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-008-0544-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,22]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["544"],"URL":"https:\/\/doi.org\/10.1007\/s00277-008-0544-2","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,22]]}}}